Table of Contents Author Guidelines Submit a Manuscript
ISRN Otolaryngology
Volume 2012 (2012), Article ID 797619, 12 pages
http://dx.doi.org/10.5402/2012/797619
Review Article

A New Strategy to Find Targets for Anticancer Therapy: Chemokine CXCL14/BRAK Is a Multifunctional Tumor Suppressor for Head and Neck Squamous Cell Carcinoma

Oral Health Science Research Center, Kanagawa Dental College, 82 Inaoka-cho, Yokosuka 238-8580, Japan

Received 29 August 2012; Accepted 14 September 2012

Academic Editors: S. L. Halum and S. C. Winter

Copyright © 2012 Ryu-Ichiro Hata. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Qichen Cao, Hua Chen, Zhili Deng, Jingwen Yue, Qi Chen, Yujing Cao, Lina Ning, and Xiaohua Lei, “Genetic deletion of Cxcl14 in mice alters uterine NK cells,” Biochemical and Biophysical Research Communications, vol. 435, no. 4, pp. 664–670, 2013. View at Publisher · View at Google Scholar
  • Xiaoyan Yang, Chihiro Miyamoto, Tetsu Akasaka, Kazuhito Izukuri, Yojiro Maehata, Takeharu Ikoma, Shigeyuki Ozawa, and Ryu-Ichiro Hata, “Chemokine CXCL14 is a multistep tumor suppressor,” Journal of Oral Biosciences, 2015. View at Publisher · View at Google Scholar
  • Ryu-Ichiro Hata, Kazuhito Izukuri, Yasumasa Kato, Soichiro Sasaki, Naofumi Mukaida, Yojiro Maehata, Chihiro Miyamoto, Tetsu Akasaka, Xiaoyan Yang, Yoji Nagashima, Kazuyoshi Takeda, Tohru Kiyono, and Masaru Taniguchi, “Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice,” Scientific Reports, vol. 5, pp. 9083, 2015. View at Publisher · View at Google Scholar